S
ALXO icon

SignatureFD’s ALX Oncology ALXO Stock Holding History

SignatureFD’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20
Closed -$223 – 3125
2024
Q1 		$223 Hold
20
– – ﹤0.01% 3089
2023
Q4 		$298 Buy
+20
New +$190 ﹤0.01% 3023
2022
Q2 		– Sell
-130
Closed -$2K – 3089
2022
Q1 		$2K Sell
130
-36
-22% -$615 ﹤0.01% 2764
2021
Q4 		$4K Buy
+166
New +$7.16K ﹤0.01% 2456
2021
Q3 		– Sell
-14
Closed -$1K – 3025
2021
Q2 		$1K Buy
+14
New +$838 ﹤0.01% 2670

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

SignatureFD's ALXO Position: Q2 2024 in Review

SignatureFD sold out of ALX Oncology (ALXO) in Q2 2024, closing a stake of 20 shares — an estimated $223 sold.

SignatureFD first reported a position in ALXO in Q2 2021 and held it in 5 quarters. The position peaked at $4K in Q4 2021. 111 funds tracked by Wall St. Rank hold ALXO as of Q2 2024.

  • SignatureFD reported no remaining ALX Oncology position as of Q2 2024 after selling out during the quarter.
  • SignatureFD sold 20 ALX Oncology shares in Q2 2024, an estimated $223.
  • SignatureFD first reported a position in ALX Oncology in Q2 2021 and held it in 5 quarters.
  • SignatureFD's ALX Oncology position peaked at $4K in Q4 2021.
  • 111 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2024.

Based on SignatureFD's 13F filing for Q2 2024, filed 29 Jul 2024.